Strategy
Research
Sharing research interests, exploring research opportunities, co-funding, sharing knowledge, avoiding duplication.
Advocacy
Encourage and inform people living with Duchenne and organizations to use their voice to inform policy in their country.
Regulatory
Enhance the relationship with regulatory and HTA & extend influence on policy makers.
Education
Engage and educate people living with Duchenne and organizations about diagnosis, standards of care, research, drug development and access to therapies.
Companies
Advocating to lessen the burden in clinical trials, expand inclusion criteria, thoughtful consideration of invasive procedures.
Clinical Trials
Including the patient voice in clinical trials by expanding inclusion criteria, lessen burden of participation, innovative designs, minimal exposure to placebo and fair pricing policies
Data
Invest in data & knowledge capturing, promoting open science, security, and data interoperability in accordance with the FAIR principles.
Outcome measures
Support the need for sensitive outcomes measures, validated biomarkers, and harmonization of regulatory decisions and working with all stakeholders in delivering access to therapies.
Copyright World Duchenne Organization © 2024